Dyslipidaemia Clinical Trial
Official title:
A Multi-center, Three-staged With Interim Analyses, Parallel, Randomized, Double-blind, fenofibrate-and Placebo-controlled Proof of Concept and Dose-response Evaluation of the Safety, Tolerability, and Effects on Plasma High-density Lipoprotein Cholesterol (HDLc) and Triglycerides of Eight Weeks Treatment With GW501516 in Otherwise Healthy Patients With Low HDLc, Mildly to Moderately Elevated Triglycerides, and Normal Low-density Lipoprotein Cholesterol (LDLc)
The purpose of this clinical research study is to compare up to 3 doses of an investigational drug GW501516 to placebo (an inactive pill that looks like GW501516) to see if it is safe, well tolerated and effective in improving (raising) low levels of "good cholesterol", high-density lipoprotein cholesterol (HDLc), as compared to placebo.
A multicentre, two-staged with interim analysis, parallel, randomised, double blind, placebo-controlled, dose-ranging study of the safety, tolerability, and effects on plasma high-density lipoprotein cholesterol (HDLc) of 12 weeks treatment with 2.5mg, 5mg and 10mg daily doses of GW501516 in subjects with low HDLc ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02230241 -
CEntralized Pan-Russian Survey of tHE Undertreatment of hypercholeSterolemia II (CEPHEUS II)
|
N/A | |
| Completed |
NCT04641299 -
A Study of AZD8233 in Participants With Dyslipidemia
|
Phase 2 | |
| Completed |
NCT01451918 -
Regulation of Intestinal and Hepatic Lipoprotein Secretion by Resveratrol
|
Phase 2 | |
| Recruiting |
NCT01212328 -
A Multi-site, Individually Randomized, Controlled Translation Trial of Integrated and Comprehensive Care Strategies to Reduce Cardiovascular Disease (CVD) Risk Among 1,120 Type 2 Diabetes Mellitus(T2DM) Patients in South Asia
|
N/A | |
| Completed |
NCT01221584 -
Centralized Pan-Russian Survey on the Undertreatment of Hypercholesterolemia
|
N/A | |
| Completed |
NCT00654225 -
Treatment of Hypercholesterolaemia in South Asian Subjects (IRIS)
|
Phase 3 | |
| Withdrawn |
NCT02557412 -
Effect of Nasal CPAP on Lipid Profile in Patients With Dyslipidaemia and Sleep Apnea
|
N/A | |
| Completed |
NCT00653965 -
Treatment of Hypercholesterolaemia in Hispanic Subjects (STARSHIP)
|
Phase 3 | |
| Recruiting |
NCT04442334 -
The European NAFLD Registry
|
||
| Completed |
NCT00653744 -
Rosuvastatin Versus Atorvastatin in the Treatment of Hypercholesterolaemia in African American Subjects(ARIES)
|
Phase 3 | |
| Completed |
NCT01632358 -
Safety and Pharmacokinetis of TAP311 in Dyslipidemic Patients
|
Phase 1 | |
| Completed |
NCT02523391 -
Bioequivalence Study of Capsule and Tablet Formulations of TA-8995
|
Phase 1 | |
| Completed |
NCT00474864 -
Study To Evaluate The Effects Of GW856553 On Endothelial Function/Vascular Compliance In Subjects With Dyslipidaemia.
|
Phase 2 | |
| Completed |
NCT00659321 -
Efficacy of Nicotine Acid on Dyslipidaemia in Patients With Metabolic Syndrome
|
Phase 3 | |
| Completed |
NCT01055977 -
Statin Therapy Results in the Real World Practice in the Czech Republic
|
N/A | |
| Completed |
NCT00654602 -
48-wk Open Label Phase IIIb to Evaluate Efficacy and Safety
|
Phase 3 | |
| Recruiting |
NCT05979428 -
A Study to Look at How Safe a New Medicine (NNC0491-6075) is in Healthy People and in Participants With High Levels of Fat in the Blood
|
Phase 1 | |
| Completed |
NCT02241759 -
Study of the Electrocardiographic Effects of TA-8995
|
Phase 1 |